S

SpringWorks Therapeutics
D

SWTX

39.030
USD
2.75
(7.58%)
Market Closed
Volume
47,047
EPS
-3
Div Yield
-
P/E
-10
Market Cap
2,903,301,309
OverviewSignalsIdeasNews
Related Instruments
    A
    AKRO
    -1.660
    (-5.58%)
    28.070 USD
    B
    BEAM
    -2.275
    (-8.65%)
    24.035 USD
    M
    MGTX
    -0.18000
    (-2.71%)
    6.47000 USD
    P
    PRVB
    -0.075
    (-0.31%)
    23.870 USD
    R
    RAPT
    -0.18000
    (-14.06%)
    1.10000 USD
    S
    SWAV
    0
    (0%)
    0.000000 USD
    V
    VYGR
    -0.57000
    (-9.18%)
    5.64000 USD
    X
    XLRN
    0
    (0%)
    0.000000 USD
    More
News

Title: SpringWorks Therapeutics

Sector: Healthcare
Industry: Biotechnology
SpringWorks Therapeutics Inc is a clinical stage biopharmaceutical company applying a precision medicine approach to acquiring, developing and commercializing life-changing medicines for underserved patient populations suffering from devastating rare diseases and cancer. The company has a differentiated portfolio of small molecule targeted oncology product candidates and is advancing two potentially registrational clinical trials in rare tumor types, as well as several otherprograms addressing highly prevalent, genetically defined cancers.